DrugPatentWatch Database Preview
Sandoz Inc Company Profile
What is the competitive landscape for SANDOZ INC, and what generic alternatives to SANDOZ INC drugs are available?
There are two US patents protecting SANDOZ INC drugs. There are fifteen tentative approvals on SANDOZ INC drugs.
There are twenty patent family members on SANDOZ INC drugs in eighteen countries and one hundred and seventy-seven supplementary protection certificates in twelve countries.
Summary for Sandoz Inc
| International Patents: | 20 |
| US Patents: | 2 |
| Tradenames: | 107 |
| Ingredients: | 103 |
| NDAs: | 135 |
| Patent Litigation for Sandoz Inc: | See patent lawsuits for Sandoz Inc |
| PTAB Cases with Sandoz Inc as petitioner: | See PTAB cases with Sandoz Inc as petitioner |
Drugs and US Patents for Sandoz Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075496-002 | Aug 22, 2000 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sandoz Inc | CIMETIDINE | cimetidine | TABLET;ORAL | 075122-002 | Jun 19, 1998 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Sandoz Inc | SILODOSIN | silodosin | CAPSULE;ORAL | 204726-001 | Mar 31, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sandoz Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077562-003 | Jun 1, 2012 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sandoz Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,252,984 | ➤ Try a Free Trial |
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,342,783 | ➤ Try a Free Trial |
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,311,708 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Sandoz Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,261,547 | Gelling ophthalmic compositions containing xanthan gum | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Sandoz Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1031335 | ➤ Try a Free Trial |
| Denmark | 1069913 | ➤ Try a Free Trial |
| Australia | 740586 | ➤ Try a Free Trial |
| Canada | 2322579 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sandoz Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 41/2009 | Austria | ➤ Try a Free Trial | PRODUCT NAME: PACLITAXEL ALBUMIN |
| C0118 | France | ➤ Try a Free Trial | PRODUCT NAME: ATORVASTATINE CALCIQUE TRIHYDRATE; REGISTRATION NO/DATE IN FRANCE: NL 21960 DU 19970321; REGISTRATION NO/DATE AT EEC: PL 00018/0240 DU 19961107 |
| 60031 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621 |
| 2017 00030 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT, SUCH AS IRINOTECAN SUCROSOFATE SALT IN A PEGYLATED LIPOSOME, SUCH AS A LIPOSOME COMPRISING 1,2-DISTEAROYL-SN-PHOSPHATIDYLCHOLINE, CHOLESTEROL AND N-(OMEGA-METHOXY-POLY(ETHYLENE GLYCOL)...; REG. NO/DATE: EU/1 /16/1130 20161018 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
